Bearbmagovva

Atopic dermatitis in 32 children treated with dupilumab in real life. A new contribution

Furkejuvvon:

Bibliográfalaš dieđut
Váldodahkkit:	Isabel Betlloch‐Mas (Dahkki), María Armengol‐García (Dahkki), Noelia Jara‐Rico (Dahkki), Ruben Hernández‐Quiles (Dahkki), Laura Berbegal DeGracia (Dahkki)
Materiálatiipa:	Girji
Almmustuhtton:	Wiley, 2024-10-01T00:00:00Z.
Fáttát:	article
Liŋkkat:	Connect to this object online.
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid

Conjunctivitis in patients with atopic dermatitis treated with dupilumab
Dahkki: Sandra Ferreira, et al.
Almmustuhtton: (2020)

Real‐world use of dupilumab for 53 patients with atopic dermatitis in Japan
Dahkki: Masako Matsutani, et al.
Almmustuhtton: (2020)

A Literature Review of Real-World Effectiveness and Safety of Dupilumab for Atopic Dermatitis
Dahkki: Masahiro Kamata, et al.
Almmustuhtton: (2021)

Purpuric Drug Eruption in a Patient with Atopic Dermatitis Treated with Dupilumab
Dahkki: Mingxia Wang, et al.
Almmustuhtton: (2022)

Immune Thrombocytopenic Purpura in a Patient with Atopic Dermatitis Treated with Dupilumab
Dahkki: Surina Frey, et al.
Almmustuhtton: (2021)

Psoriasis‐like eruptions developed in an atopic dermatitis patient treated with dupilumab
Dahkki: Rai Fujimoto, et al.
Almmustuhtton: (2022)

Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis
Dahkki: Tiago Torres, et al.
Almmustuhtton: (2024)

Experience with dupilumab in patients with atopic dermatitis
Dahkki: E. A. Glukhova, et al.
Almmustuhtton: (2023)

Dupilumab for the treatment of atopic dermatitis of the elderly: a real-life 52-week experience
Dahkki: Luigi Gargiulo, et al.
Almmustuhtton: (2023)

Reduction in hospitalisations with dupilumab in Japanese adults with atopic dermatitis in a real‐world setting
Dahkki: Ken Igawa, et al.
Almmustuhtton: (2023)

Dupilumab in pediatric atopic dermatitis: real-world evidence from two national centers
Dahkki: Gilberto P. da Rosa, et al.
Almmustuhtton: (2024)

Recalcitrant erythrodermic ichthyosis with atopic dermatitis successfully treated with Dupilumab in combination with Guselkumab
Dahkki: M. Steinhoff, et al.
Almmustuhtton: (2022)

Transitory Dissemination of Molluscum Contagiosum in a Patient Treated with Dupilumab for Atopic Dermatitis
Dahkki: Silvia Ferrucci, et al.
Almmustuhtton: (2020)

Alcohol-induced facial flushing in a patient with atopic dermatitis treated with dupilumab
Dahkki: Sean J. Igelman, BS, et al.
Almmustuhtton: (2020)

A Case of Sézary Syndrome in a Patient Treated with Dupilumab for Atopic Dermatitis
Dahkki: Kaito Muramatsu, et al.
Almmustuhtton: (2024)

Efficacy of dupilumab in moderate and severe atopic dermatitis
Dahkki: Stephan Weidinger, et al.
Almmustuhtton: (2023)

Dupilumab in the Treatment of Cheilitis in Atopic Dermatitis Patients
Dahkki: Shan J, et al.
Almmustuhtton: (2022)

Alopecia areata after dupilumab for atopic dermatitis
Dahkki: Krystal Mitchell, MBA, et al.
Almmustuhtton: (2018)

Onychodystrophy associated with dupilumab therapy for atopic dermatitis
Dahkki: Amanda E. Zubek, MD, PhD, et al.
Almmustuhtton: (2021)

Dupilumab Treatment in Atopic Dermatitis: Real-World Evidence from a Portuguese Tertiary Center
Dahkki: Tomás Pessoa e Costa, et al.
Almmustuhtton: (2021)

Five-year real-world drug survival of dupilumab in severe atopic dermatitis and associate predictors
Dahkki: Francesca Barei, et al.
Almmustuhtton: (2024)

Atopic dermatitis: real-life experience with tralokinumab after dupilumab failure: a case series
Dahkki: Patrícia Amoedo, et al.
Almmustuhtton: (2024)

Dupilumab in Patients with Atopic Dermatitis: A Multicentric, Long-Term, Real-World Portuguese Study
Dahkki: Tiago Torres, et al.
Almmustuhtton: (2024)

Recalcitrant Palmar-Plantar Atopic Dermatitis Successfully Treated with Dupilumab: A Case Series
Dahkki: Deng L, et al.
Almmustuhtton: (2022)

Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report
Dahkki: Liu L, et al.
Almmustuhtton: (2023)

Comparison of safety profile in patients with atopic dermatitis treated with dupilumab or conventional systemic treatment: real world data from the US network
Dahkki: Henner Zirpel, et al.
Almmustuhtton: (2024)

Scabies in Infants: Series of 51 Cases
Dahkki: Isabel Betlloch-Mas, et al.
Almmustuhtton: (2024)

Uveitis and hypereosinophilia associated with dupilumab in an atopic dermatitis patient
Dahkki: Shiyu Zhang, et al.
Almmustuhtton: (2023)

Dupilumab normalizes correlates of lysosomal function in atopic dermatitis
Dahkki: Christina Bürgler, et al.
Almmustuhtton: (2024)

Dupilumab in atopic dermatitis patients with chronic hepatitis B
Dahkki: Masako Matsutani, et al.
Almmustuhtton: (2022)

Dupilumab for the treatment of alopecia areata in children with atopic dermatitis
Dahkki: Sung Kyung Cho, BA, et al.
Almmustuhtton: (2021)

The application of the biological treatment in atopic dermatitis: focus on dupilumab
Dahkki: Yu. S. Smolkin, et al.
Almmustuhtton: (2023)

Identification of clinical predictors for dupilumab dose spacing in adults with atopic dermatitis: a real-world study
Dahkki: Andrea Chiricozzi, et al.
Almmustuhtton: (2023)

Real‐world effectiveness and safety of dupilumab in patients with moderate and severe atopic dermatitis: 2‐year experience
Dahkki: Chisako Fujiwara, et al.
Almmustuhtton: (2023)

Clinical remission of disseminated molluscum contagiosum infection in a patient with atopic dermatitis treated with dupilumab
Dahkki: Marta Elosua-González, et al.
Almmustuhtton: (2022)

Atopic Dermatitis Treated Safely with Dupilumab during Pregnancy: A Case Report and Review of the Literature
Dahkki: Yolanka Lobo, et al.
Almmustuhtton: (2021)

COVID-19 in Patients with Atopic Dermatitis Treated with Dupilumab: Three Cases and a Literature Review
Dahkki: Ceryn J, et al.
Almmustuhtton: (2021)

Dupilumab Provides Rapid and Sustained Improvement in SCORing Atopic Dermatitis Outcomes in Paediatric Patients with Atopic Dermatitis
Dahkki: Andreas Wollenberg, et al.
Almmustuhtton: (2022)

Long-term Remission of Atopic Dermatitis after Discontinuation of Dupilumab
Dahkki: Shoko Miyamoto, et al.
Almmustuhtton: (2022)

Eye Complications During Dupilumab Treatment for Severe Atopic Dermatitis
Dahkki: Lina U. Ivert, et al.
Almmustuhtton: (2019)